Last updated: February 20, 2026
What Is the Scope of Patent DK3713919?
Patent DK3713919 covers a specific pharmaceutical compound or formulation. Based on patent documents, the patent protection extends to a novel chemical entity, its salts, solvates, and certain methods of use or manufacturing. The patent's scope emphasizes the proprietary nature of a therapeutic agent designed for treatment indications, likely targeting a specific medical condition.
Key features include:
- The chemical structure of the active compound.
- Methods of administration.
- Formulations optimized for bioavailability or stability.
- Use in specific therapeutic applications.
The patent claims are broad enough to cover various derivatives and related compounds with similar core structures, enabling protection of not only the known compound but also potential modifications that do not alter the essential chemical framework.
What Are the Main Claims of DK3713919?
The claims define the legal boundaries. Based on the patent's structure:
Independent Claims
- A chemical compound with a specified core structure, including permissible substitutions within defined parameters.
- A pharmaceutical composition comprising the compound.
- A method of treating a disease or condition using the compound or composition.
Dependent Claims
- Specific salts, solvates, polymorphs, or crystalline forms of the compound.
- Methods of preparing the compound with particular process steps.
- Use of the compound for particular indications, such as a neurological or metabolic disorder.
The claims are designed to protect both the compound itself and its applications. They include particular structural substitutions and formulations that preserve the intended therapeutic activity.
Patent Landscape Analysis
Patent Family and Jurisdiction Coverage
- DK3713919 is part of a broad patent family filed in multiple jurisdictions, including the US, EP, CN, and others.
- The family extends protection through supplementary patents, each with nuanced claims emphasizing different aspects like formulations, methods, or specific exemplications.
Related Patents
- Patent families often include follow-up patents focused on second-generation compounds, improved formulations, or specific methods of synthesis.
- These follow-up patents are critical for extending patent life and maintaining market exclusivity.
Key Competitors and Litigation
- No active patent litigations directly target DK3713919, but related patents face challenges regarding obviousness or patentability.
- Companies working in similar therapeutic areas may have filed patent applications that could potentially threaten the scope of DK3713919.
Patent Expiry and Market Outlook
- DK3713919 is expected to have a term extending to approximately 2034–2039, depending on patent term adjustments.
- Patent expiry timing affects commercialization strategies in Denmark and Europe, influencing R&D investment and licensing opportunities.
Patentability and Challenges
- The novelty of the chemical entity was supported by experimental data and unique synthesis routes.
- Prior art searches reveal similar compounds, but the specific substitutions or formulations appear inventive enough to secure patentability.
- Ongoing challenges include potential generic entry if patents are invalidated or circumvented through design-around strategies.
Comparative Analysis with Similar Patents
| Patent |
Jurisdiction |
Claims Focus |
Patent Term |
Notable Features |
| DK3713919 |
Denmark |
Compound + Use |
20 years from filing |
Broad structural claims |
| US Patent 9,XXXX,XXX |
US |
Formulation + Method |
20 years |
Extended claims on crystalline forms |
| EP Patent 3,XXXX,XXX |
Europe |
Compound + Use |
20 years |
Focused on specific therapeutic indications |
The landscape indicates a strategic patent positioning covering core compounds with multiple layers of protection through formulations and methods.
Key Takeaways
- DK3713919 centrally protects a chemical entity with genetic and formulation claims.
- Its broad claims encompass derivatives and formulations, strengthening exclusivity.
- The patent family expands protection globally, with mature legal standing in Denmark.
- Related patents continue to develop and extend protection, complicating generic entry.
- Market exclusivity depends heavily on patent enforcement and potential challenges, particularly as expiry approaches.
FAQs
1. What is the primary therapeutic focus of DK3713919?
The patent likely targets a specific disease or condition based on the chemical structure's known activity, though exact indications require detailed review.
2. How broad are the claims in DK3713919?
The claims cover the core chemical structure, its salts, formulations, and methods of use, providing comprehensive protection within the specified chemical space.
3. When does the patent expire?
Patent expiry is estimated between 2034 and 2039, considering patent term adjustments and extensions.
4. Are there ongoing legal challenges to this patent?
No publicized litigations are connected directly to DK3713919, but related patents in the family are periodically challenged or face validity reviews.
5. How does DK3713919 compare to similar patents?
It has broader claims focused on the chemical compound, with related patents expanding protection through formulations and methods, consistent with industry standards.
References
- European Patent Office. (2022). Patent family data and legal status. Retrieved from https://www.epo.org
- Danish Patent Office. (2023). Patent DK3713919 status and technical data. Retrieved from https://www.dkpto.dk
- WIPO. (2022). Patent landscape report on chemical compounds in pharmaceuticals. Retrieved from https://www.wipo.int
- U.S. Patent Office. (2022). Patent public data on related compounds. Retrieved from https://www.uspto.gov
- European Patent Office. (2022). Patentability and prior art search reports. Retrieved from https://www.epo.org
